1/19
01:04 pm
mrna
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Moderna (NASDAQ:MRNA) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
1/15
03:27 pm
mrna
Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results [Yahoo! Finance]
Low
Report
Moderna (MRNA) Rockets 17% on Strong Preliminary FY25 Results [Yahoo! Finance]
1/14
07:36 am
mrna
The 20 stocks most shorted by hedge funds [Seeking Alpha]
Medium
Report
The 20 stocks most shorted by hedge funds [Seeking Alpha]
1/13
08:42 am
mrna
Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story [Seeking Alpha]
High
Report
Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story [Seeking Alpha]
1/12
04:11 pm
mrna
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
High
Report
Moderna (NASDAQ:MRNA) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/12
04:11 pm
mrna
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
High
Report
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
1/12
08:32 am
mrna
Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors [Yahoo! Finance]
Medium
Report
Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors [Yahoo! Finance]
1/6
05:04 pm
mrna
Moderna (NASDAQ:MRNA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
Low
Report
Moderna (NASDAQ:MRNA) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.
1/5
02:10 pm
mrna
Moderna (NASDAQ:MRNA) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Moderna (NASDAQ:MRNA) had its "hold" rating reaffirmed by analysts at Jefferies Financial Group Inc..
1/5
07:13 am
mrna
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine [Yahoo! Finance]
Medium
Report
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine [Yahoo! Finance]
12/25
06:03 am
mrna
Age of breakthroughs: More from The Globe and Mail [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Age of breakthroughs: More from The Globe and Mail [Globe and Mail, The (Toronto, Canada)]
12/23
02:45 pm
mrna
Moderna: Why I Am Selling The 'Relief Rally' [Seeking Alpha]
Low
Report
Moderna: Why I Am Selling The 'Relief Rally' [Seeking Alpha]
12/19
08:05 pm
mrna
Moderna, Inc. (MRNA): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Moderna, Inc. (MRNA): A Bull Case Theory [Yahoo! Finance]
12/17
10:11 am
mrna
HFA Architecture + Engineering Taps Sherwood Butler as Vice President [Yahoo! Finance]
Medium
Report
HFA Architecture + Engineering Taps Sherwood Butler as Vice President [Yahoo! Finance]
12/17
07:16 am
mrna
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/12
12:00 pm
mrna
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Morgan Stanley.
Low
Report
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Morgan Stanley.
12/11
09:06 pm
mrna
Moderna (NASDAQ:MRNA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) is now covered by analysts at Jefferies Financial Group Inc.. They set a "hold" rating on the stock.
12/9
09:25 am
mrna
Global AI Infrastructure Shift Ignites Biotech Growth Phase
Low
Report
Global AI Infrastructure Shift Ignites Biotech Growth Phase
12/1
11:04 am
mrna
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
11/21
01:06 pm
mrna
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/21
10:10 am
mrna
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
Medium
Report
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
11/21
09:47 am
mrna
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
11/21
09:47 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
11/21
09:09 am
mrna
Moderna (NASDAQ:MRNA) was given a new $63.00 price target on by analysts at Piper Sandler.
Medium
Report
Moderna (NASDAQ:MRNA) was given a new $63.00 price target on by analysts at Piper Sandler.
11/20
04:01 pm
mrna
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.